PE firms eye Shanghai Pharma

One of China’s largest pharmaceutical groups is attracting interest from private equity firms after reportedly announcing that it wants to sell a large stake to foreign buyers.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this